Sugammadex-Mepha 500 mg/5 ml, Injektionslösung
7680690000028
CH-69000
Injektionslösung
Associated product:
SUGAMMADEX Mepha sol inj 500 mg/5ml 10 pce
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
544.0 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
48.5 MG | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69000
- Drug name
- Sugammadex-Mepha, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V03AB35
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 21/07/2023
- Authorization expiration date
- 20/07/2028
- IT Number
- 15.01.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SUGAMMADEX Mepha sol inj 500 mg/5ml 10 pce
- Description (DE)
- SUGAMMADEX Mepha Inj Lös 500 mg/5ml 10 Stk
- Market launch
- 21/07/2023
- Narcotic (BTM)
- No
Other package sizes (1)
SUGAMMADEX Mepha sol inj 200 mg/2ml 10 pce
10 DUR
GTIN: 7680690000011